Thus, we identified the possibility of an early therapeutic strategy targeting the LIMK2/Cofilin pathway to alleviate post-RP ED through improvement of cavernosal fibrosis caused by CNCI. The gene discussed is CFL1; the disease is retinitis pigmentosa 1.